Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DISCOMS: Discontinuation of DMTs in MS
NCT03073603Phase 4Completed
- Sponsor
- University of Colorado Denver
- Start
- Apr 2017
- Primary completion
- Aug 2021
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial in multiple sclerosis (MS) (2 arms), sponsored by University of Colorado Denver. Primary endpoint: Number of Participants Developing a New MS Relapse and/or MRI Brain Lesion Over the Course of the Study Duration. Started Apr 2017; status: completed.
02
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT03073603.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03073603.